GWR Medical, Inc., founded in 1996, is the leading provider of Topical Oxygen Therapy (TO2™) for the healing of chronic wounds. The company's sales force calls on physicians to utilize GWR's FDA approved Topical Oxygen Therapy Devices and Therapy Protocol to treat their patients with non-healing wounds such as diabetic ulcers, pressure sores, venous stasis ulcers, burns, trauma and post-op wounds in any patient setting, but mostly, in the home. The efficacy of the therapy is validated by the use of WoundMatrix, Inc.'s, WoundMatrix Web proprietary digital imaging software. WoundMatrix precisely measures the exact surface area of the wound and produces outcomes documentation for the doctors, patients and the insurance companies. WoundMatrix is utilized and recognized by many professional, government and educational facilities as the most precise tool available for measuring and reporting wound outcomes.